Prognostic value of des-γ-carboxyprothrombin in patients with AFP-negative HCC treated with TACE.

ABSTRACT: In patients with AFP-negative hepatocellular carcinoma (HCC), des-γ-carboxyprothrombin (DCP) is an important prognostic indicator for the preoperative assessment of transarterial chemoembolization (TACE). However, the association between the serum DCP levels and the degree of progression and prognosis of patients with AFP-negative HCC treated with TACE has not been thoroughly investigated to date, and the molecular mechanism is also unclear. The present study retrospectively analyzed the clinical data of 107 patients with AFP-negative HCC treated with TACE and divided them into two groups based on the median serum DCP levels. The association between DCP and the clinical characteristics of the patients was analyzed, and the survival data were analyzed using Kaplan-Meier curves and Cox regre

SUBMITTER: Sun H 

PROVIDER: S-EPMC9827467 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature